Skip to content
Clinical Trials – home
Therapeutic area

Gastrointestinal disorders – page 50

  • 1 123 clinical trials
  • 490 recruiting
  • 469 conditions
  • 28 countries

Conditions in this area

469 conditions with trials, the busiest first

Clinical trials in Gastrointestinal disorders

1 123 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

1 123 clinical trials

Anal cancer

Not yet recruiting

Study of Pembrolizumab with Standard Chemoradiation for Patients with Advanced Anal Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Cardiff University

Rectal cancer

Not yet recruiting

Study on Organ Preservation in Advanced Rectal Cancer Patients Using Bleomycin and Electrochemotherapy After Initial Treatment

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale

Gastric cancer+6

Not yet recruiting

Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
  • Sponsor:Universitaetsklinikum Essen AöR

Anal fissure

Not yet recruiting

Study on Treating Chronic Anal Fissure in Patients Using Ultrasound-Guided Injections of Botulinum Toxin A

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Hospital Universitario de Burgos

Salivary gland cancer

Not yet recruiting

Study of Capecitabine for Patients with Recurrent or Metastatic Salivary Duct Carcinoma

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Stichting Radboud University Medical Center

Colitis ulcerative+1

Not yet recruiting

Study on Fecal Microbiota Transplantation with Infliximab and Vedolizumab for Patients with Ulcerative Colitis

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Varsinais-Suomen hyvinvointialue

Appendicitis

Not yet recruiting

Study Comparing Antibiotic Treatment with Placebo for Patients with Acute Appendicitis Using Ertapenem, Metronidazole, and Levofloxacin

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Ertapenem
  • Sponsor:Turku University Hospital

Appendicitis

Not yet recruiting

Study on the Effectiveness and Safety of Amoxicillin, Clavulanic Acid, and Metronidazole for Treating Acute Appendicitis in Children Aged 7 to 18

Registered drugNo placebo
Countries:LatviaLatvia
  • Participants:0–17 years
  • Substances:Amoxicillin
  • Sponsor:Riga Stradins University

Anal incontinence

Not yet recruiting

Study on the Safety and Effectiveness of Allogeneic Adipose-Derived Adult Mesenchymal Stem Cells for Treating Fecal Incontinence in Patients

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Adipose-Derived Adult Mesenchymal Stem Cells Expanded
  • Sponsor:Fundacion Publica Andaluza Para La Investigacion De Malaga En Biomedicina Y Salud

Study Comparing Secretin Synthetic Human and Endoscopic Aspiration Techniques for Analyzing Pancreatic Cancer in Patients with Intraductal Papillary Mucinous Neoplasia

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:SECRETIN SYNTHETIC HUMAN
  • Sponsor:Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer

Appendicitis

Not yet recruiting

Study on Pain Management in Children Aged 7-18 with Acute Appendicitis Using Ketorolac Trometamol

Registered drugNo placebo
Countries:LatviaLatvia
  • Participants:0–17 years
  • Substances:KETOROLAC TROMETAMOL
  • Sponsor:Riga Stradins University

Colon cancer

Not yet recruiting

Study on Pembrolizumab and Drug Combination for Patients with Localized Colon Cancer with Specific Genetic Markers

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Association Gercor

Substances studied in this area

The therapies tested most often in Gastrointestinal disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.